Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Nov 2026

Psychedelic-assisted therapies (Psilocybin and MDMA) for treatment-resistant psychiatric disorders

Objective: To describe the pharmacological mechanisms, clinical efficacy, and safety of psilocybin- and MDMA-assisted therapies for depression and post-traumatic stress disorder (PTSD), while critically examining the methodological limitations of current evidence. Methods: This narrative, non-systematic literature revi...

Maria Luíza Gurgel, Ana Luísa Carrijo Ferreira, Luisa da Costa Mello et al. · 0 citations
Oct 2026

Social vulnerability as a key dimension of frailty in Alzheimer’s disease and frontotemporal dementia

A timely periodic evaluation of non-physical determinants of vulnerability may contribute to a better and earlier detection of maladaptive trajectories with a consequent beneficial effect on the well-being and burden of the patient-caregiver dyad.

Andrea Panzavolta, Alessandra Dodich, M. Picascia et al. · 0 citations
Open access Sep 2026

Incremental Value of CSF Biomarker-Integrated Classification of Cerebral Amyloid Angiopathy

The CSF biomarker-integrated reclassification significantly improved the distinction between subgroups regarding CAA- and arteriosclerosis-related MRI features and support a future transition toward an integrated biological-radiological framework, which may refine in vivo CAA diagnosis, particularly in mixed SVD.

M. Losa, M. C. Ramusino, I. Gandoglia et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.